Leading the psychedelic renaissance
As you explore the promising world of psychedelic healing, MAPS is your partner for science-based information, learning, and experiences.
Join the MAPS movement
MAPS featured in new Netflix series
Check out Netflix’s provocative new docuseries on psychedelics, How to Change Your Mind. This four-episode limited series is based on bestselling author Michael Pollan’s book by the same name. Episode three focuses heavily on MAPS work as a leader in the psychedelic movement.
Begin your psychedelic learning journey with MAPS
Our Psychedelic Fundamentals course is the perfect starting point for those considering psychedelic use, seeking information to support a loved one, or interested in how psychedelics work and what benefits they may provide.
Help Us Deliver Global Healing
Every dollar that MAPS has raised for psychedelic research and therapy been donated by people like you. Your tax-deductible contributions are what allow MAPS to pursue the important and challenging work of psychedelic research, drug policy reform, public education, health equity, and harm reduction initiatives.
Thanks for your contribution to MAPS!
Your tax-deductible contribution supports psychedelic science research, drug policy reform, public education, harm reduction, peer support, and our general operations.
MAPS in the News
Fox Business: The FDA Could Approve MDMA-Assisted Therapy by 2024: Rick Doblin, Ph.D.
The New York Times: A Balm for Psyches Scarred by War
Harvard Med: Altering Perceptions on Psychedelics
PBS: Healthy Minds With Dr. Jeffrey Borenstein: Psychedelic-Assisted Psychotherapy and Post-Traumatic Stress with Rachel Yehuda
Forbes: Exclusive: MAPS Accepts $500,000 Donation From Atai Life Sciences’ Philanthropy Arm
CBS News: Using Psychedelics to Treat Veterans’ PTSD
The New York Times: Veterans Have Become Unlikely Lobbyists in Push to Legalize Psychedelic Drugs
Matters Arising: MAPS’ Pivotal Phase 3 Trial Advances Scientific Discourse in Nature Medicine
The Intercept: Party Drugs for PTSD: Study Moves Therapeutic Use of MDMA Toward Approval
The Psychedelic Podcast by Third Wave: Healing the Heart of Humanity: Legalizing Psychedelic Medicine
High Times: House Lawmakers Launch Bipartisan Psychedelics Caucus
Psychedelic Spotlight: The Psychedelics Industry in 2022 Was a Wild Ride
Thanks to the innovative and passionate thinkers across the country, MAPS has been able to uncover even more about the potential for psychedelic healing for mass mental health.
In 2014, after years of positive growth, we launched MAPS Public Benefit Corporation (MAPS PBC)—our sister in psychedelic research. The goal of MAPS PBC is to catalyze healing and well-being through psychedelic drug development, therapist training programs, and, ultimately, the sales of prescription psychedelics. MAPS PBC, a wholly owned subsidiary of MAPS, prioritizes patients over profit and is driven by core values that promote sustainability, accountability, transparency, and equitable access to care.
Explore our research
We’ve come a long way from the counterculture movement of the 1960’s—and, thanks to decades of studies, so has our data. We now understand more about the healing powers of psychedelics than ever before, and we’re excited to share our findings with you and the world.
